Cost-effectiveness intervention thresholds for romosozumab and teriparatide in the treatment of osteoporosis in the UK
Fredrik Borgström, Mattias Lorentzon, Helena Johansson, Nicholas C. Harvey, Eugene McCloskey, D. Willems, Douglas Knutsson, John A Kanis
Topics & Concepts
TeriparatideMedicineOsteoporosisRheumatologyInternal medicineIntervention (counseling)Bone mineralNursingBone health and osteoporosis researchBone Metabolism and DiseasesHip and Femur Fractures